University Hospital, Geneva
Clinical trials sponsored by University Hospital, Geneva, explained in plain language.
-
Custom-Made cancer vaccine shows promise in early trial
Disease control OngoingThis early-phase study tests a personalized immunotherapy called MVX-ONCO-2 in 6 adults with advanced solid tumors that have not responded to standard treatments. The vaccine is made from the patient's own tumor cells and aims to boost the immune system to fight the cancer. The m…
Phase: PHASE1 • Sponsor: University Hospital, Geneva • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Psychedelic therapy under the microscope: did intensity matter?
Knowledge-focused OngoingThis study reviewed medical records of 376 people who received LSD or psilocybin therapy for hard-to-treat depression, anxiety, or addiction. Researchers wanted to see if the intensity of the psychedelic experience was linked to better outcomes. No new treatments were given—only …
Sponsor: University Hospital, Geneva • Aim: Knowledge-focused
Last updated May 05, 2026 11:57 UTC